Human CD196/CCR6 HEK293T Stable Cell Line

The Structure and Activity of Human CD196/CCR6 HEK293T Stable Cell Line

The Human CD196/CCR6 HEK293T Stable Cell Line is a valuable tool for studying the role of the chemokine receptor CD196/CCR6 in various cellular processes. This cell line is derived from the human embryonic kidney cell line HEK293T and has been stably transfected with the gene for CD196/CCR6, allowing for the continuous expression of this receptor.

Structure of CD196/CCR6

CD196/CCR6 is a G protein-coupled receptor (GPCR) that is primarily expressed on the surface of immune cells, including T cells, B cells, and dendritic cells. It is composed of seven transmembrane domains and has a molecular weight of approximately 40 kDa. The extracellular region of CD196/CCR6 contains several conserved cysteine residues, which are important for the formation of disulfide bonds and the overall stability of the receptor.
The intracellular region of CD196/CCR6 contains several motifs that are involved in signaling, including a G protein-binding site, a phosphorylation site, and a PDZ-binding domain. These motifs play a crucial role in the activation and regulation of CD196/CCR6 signaling pathways.

Activity of CD196/CCR6

CD196/CCR6 is a chemokine receptor that specifically binds to the chemokine CCL20, also known as macrophage inflammatory protein 3 alpha (MIP-3α). Upon binding to its ligand, CD196/CCR6 triggers a signaling cascade that leads to the activation of various downstream pathways, including the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways. These pathways are involved in regulating cell migration, proliferation, and survival.
In addition to its role in immune cell function, CD196/CCR6 has also been implicated in various disease processes. Studies have shown that this receptor is involved in the development and progression of inflammatory diseases, such as rheumatoid arthritis and psoriasis. It has also been linked to the pathogenesis of certain types of cancer, including breast, ovarian, and colorectal cancer.

Application of CD196/CCR6 HEK293T Stable Cell Line

The CD196/CCR6 HEK293T Stable Cell Line has numerous applications in both basic research and drug discovery. One of its main uses is in the study of CD196/CCR6 signaling pathways and its role in various cellular processes. This cell line can be used to investigate the effects of different ligands on CD196/CCR6 activation and downstream signaling events.
Another important application of this cell line is in drug discovery and development. CD196/CCR6 has been identified as a potential therapeutic target for various diseases, and the CD196/CCR6 HEK293T Stable Cell Line can be used to screen for novel compounds that can modulate its activity. This can aid in the development of new treatments for inflammatory diseases and cancer.

Flow Cytometry Analysis

The CD196/CCR6 HEK293T Stable Cell Line can also be used for flow cytometry analysis, a powerful technique that allows for the identification and characterization of cells based on their surface markers. By staining the cells with antibodies against CD196/CCR6, researchers can analyze the expression levels of this receptor on the cell surface, as well as its internalization and trafficking patterns.
In conclusion, the Human CD196/CCR6 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of CD196/CCR6 in various cellular processes. Its use in basic research and drug discovery has the potential to advance our understanding of this important chemokine receptor and its role in disease.